Recepta Biopharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Recepta Biopharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10883
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Recepta Biopharma SA (Recepta) is a biotechnology company that offers research and development of drugs used in the treatment of cancer. The company offers antibodies and peptide products. It offers antibodies such as monoclonal antibody hu3s193 – anti-ley, monoclonal antibody 58-1066 – anti-leb, monoclonal antibody mx35, and monoclonal antibody a34. Recepta conducts research at different stages of development to produce other mAbs for the treatment of cancer. The company partners with cancer research institutes, medical faculties, hospital centers and laboratories. Recepta is headquartered in Itaim Bibi, Brazil.

Recepta Biopharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recepta Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
BNDES Invests USD14.5 Million in Recepta Biopharma 10
Partnerships 11
4-Antibody And Ludwig Institute Enter Into Agreement With Recepta Biopharma For Oncology Research 11
Licensing Agreements 12
Mersana Therapeutics Enters into Licensing Agreement with Recepta Biopharma 12
Recepta Biopharma SA – Key Competitors 13
Recepta Biopharma SA – Key Employees 14
Recepta Biopharma SA – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Key Facts 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recepta Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recepta Biopharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BNDES Invests USD14.5 Million in Recepta Biopharma 10
4-Antibody And Ludwig Institute Enter Into Agreement With Recepta Biopharma For Oncology Research 11
Mersana Therapeutics Enters into Licensing Agreement with Recepta Biopharma 12
Recepta Biopharma SA, Key Competitors 13
Recepta Biopharma SA, Key Employees 14

List of Figures
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Recepta Biopharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magenta Therapeutics Inc (MGTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Magenta Therapeutics Inc (Magenta Therapeutics) formerly HSCTCo Therapeutics Inc, is a clinical-stage biotechnology company focused on developing novel medicines which revolutionizes bone marrow transplant for treating autoimmune diseases, blood cancers and rare genetic diseases. Its product …
  • LafargeHolcim Ltd.:企業のM&A・事業提携・投資動向
    LafargeHolcim Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LafargeHolcim Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Gelsenwasser AG (WWG):企業の財務・戦略的SWOT分析
    Summary Gelsenwasser AG (Gelsenwasser) is a utility company that supplies natural gas and fresh water. The company distributes electricity, water, gas, and heat for residents in Germany. Its services include online service, repair services, energy performance certifications, debugging and installati …
  • Fubon Insurance Co., Ltd.:企業の戦略的SWOT分析
    Fubon Insurance Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Itochu Corporation (8001)-石油・ガス分野:企業M&A・提携分析
    Summary Itochu Corporation (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, in …
  • The People’s Insurance Company (Group) of China Limited:企業の戦略・SWOT・財務情報
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Laissez-Faire Catering Pty Ltd:企業の戦略・SWOT・財務分析
    Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ITM Power Plc (ITM)-エネルギー分野:企業M&A・提携分析
    Summary ITM Power Plc (ITM Power) is a renewable energy company. It designs and manufactures hydrogen energy systems for clean fuel production and energy storage. The company develops equipment to convert renewable energy to a clean fuel that can be stored for use in transport, industrial, and resid …
  • Vietnam National Petroleum Group (PLX):企業の財務・戦略的SWOT分析
    Vietnam National Petroleum Group (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Aldi Einkauf GmbH & Co oHG:企業の戦略・SWOT・財務情報
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Royal Dutch Shell Plc (RDSA)-エネルギー分野:企業M&A・提携分析
    Summary Royal Dutch Shell plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • Longfor Properties Co., Ltd.:戦略・SWOT・企業財務分析
    Longfor Properties Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Longfor Properties Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • The Gunma Bank Ltd:企業の戦略・SWOT・財務分析
    The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Troy Resources Limited:企業の戦略・SWOT・財務分析
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hess Corporation:企業の戦略・SWOT・財務情報
    Hess Corporation - Strategy, SWOT and Corporate Finance Report Summary Hess Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Avanti Energy Inc (AVN):石油・ガス:M&Aディール及び事業提携情報
    Summary Avanti Energy Inc (Avanti Energy), formerly Overlord Capital Ltd is an oil and gas exploration and production company. The company acquires, explores and develops gas reserves in Central Italy. It re-develops the existing oil and gas reserves. Avanti Energy re-enters and drills new wells in …
  • EnBW Energie Baden-Wurttemberg AG (EBK)-エネルギー分野:企業M&A・提携分析
    Summary EnBW Energie Baden-Wuerttemberg AG (EnBW) is an integrated energy holding company that generates, procures, transmits and supplies electricity; and produces, transports and supplies gas through its subsidiaries. Its generation portfolio includes nuclear, coal, oil, gas, wind, and pumped stor …
  • Oxtex Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxtex Ltd (Oxtex), formerly Oxtexs Ltd is a medical device company that offers novel self inflating tissue expansion and medical devices. The company’s products include implantable self-inflating tissue expanders that are suitable for specific needs of the clinician and the patient. It uses …
  • Energy Development Corp (EDC):電力:M&Aディール及び事業提携情報
    Summary Energy Development Corp (EDC), formerly Philippine National Oil Company, is a diversified renewable energy company. The company explores, develops, operates and utilizes geothermal energy and other indigenous renewable energy projects in the Philippines. EDC by utilizing geothermal energy an …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務分析
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆